Overall rank by patents
#15,917
Across all tracked assignees
USPTO PatentsView assignee record - 18 granted patents across 10 technology areas, active 2021–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
The verdict
Catalent holds 18 US patents across 10 technology areas, rank #15,917 of 50,000 tracked assignees.
Catalent U.k. Swindon Zydis Limited has been granted 18 US utility patents between 2021 and 2025, placing Catalent U.k. Swindon Zydis Limited at rank #15,917 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.3 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, Catalent U.k. Swindon Zydis Limited is one of the more focused assignees in the PatentsView dataset. By volume, Catalent sits between Canaan Creative Co., Ltd. (18 patents, rank #15,913) and Changzhou Jutal Electronic Co., Ltd. (18 patents, rank #15,921) - the closest US assignees by grant volume. The composite Innovation Score of 38.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2021 through 2025, with 18 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Catalent U.k. Swindon Zydis Limited's 19.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Catalent U.k. Swindon Zydis Limited against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Canaan Creative Co., LTD.
18 patents
Cantargia AB
18 patents
Cardiva Medical, Inc.
18 patents
Carl Geringhoff GmbH & Co. KG
18 patents
Century Plastics, LLC
18 patents
Ceva D.S.P. Ltd.
18 patents
Changzhou Globe Co., Ltd.
18 patents
Changzhou Jutal Electronic Co., Ltd.
18 patents
Catalent U.K. Swindon Zydis Limited
18 patents
What this shows Catalent holds 18 patents at rank #15,917, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #15,917 in granted patent volume.
Other assignees with the most granted patents in Catalent's primary technology class.
Catalent's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
38 Top 42% higher than 58% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2021 | 8 | 44.4% |
| 2022 | 3 | 16.7% |
| 2023 | 1 | 5.6% |
| 2024 | 2 | 11.1% |
| 2025 | 4 | 22.2% |
Top 10 of 10 technology areas
Overall rank by patents
#15,917
Across all tracked assignees
38.0 out of 100
How to use this portfolio
Catalent's 18 grants land it in the top 42% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.